Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients

American Journal of Psychiatry

Volumn 156, Issue 12, 1999, Pages 1909-1914

  Frye, Mark A ^b   Denicoff, Kirk D ^b   Bryan, Ann L ^b   Smith Jackson, Earlian E ^b   Ali, S Omar ^b   Luckenbaugh, David ^b   Leverich, Gabriele S ^b   Post, Robert M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LITHIUM;

ARTICLE; CLINICAL ARTICLE; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FREE THYROXINE INDEX; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; MOOD; PRIORITY JOURNAL; RATING SCALE; THYROID HORMONE BLOOD LEVEL;

AFFECT; BIPOLAR DISORDER; CARBAMAZEPINE; COMORBIDITY; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOTHYROIDISM; INCIDENCE; LITHIUM; MALE; SEVERITY OF ILLNESS INDEX; THYROXINE; TREATMENT OUTCOME;

EID: 0032697377     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Kirkegaard C, Faber J: The role of thyroid hormones in depression. Eur J Endocrinol 1998; 138:1-9
2. Joffe RT, Sokolov STH: Thyroid hormones, the brain, and affective disorders. Crit Rev Neurobiol 1994; 8:45-63
3. Bauer MS, Whybrow PC: Thyroid hormones and the central nervous system in affective illness: interactions that may have clinical significance. Integrative Psychiatry 1988; 6:75-85
4. Villeneuve A, Gautier J, Jus A, Perron D: The effect of lithium on thyroid in man. Int J Clin Pharmacol 1974; 9:75-80
5. Emerson CH, Dyson WL, Utiger RD: Serum thyrotropin and thyroxine concentrations in patients receiving lithium carbonate. J Clin Endocrinol Metab 1973; 36:338-346
6. Myers DH, Carter RA, Burns BH, Armond A, Hussain SB, Chengapa VK: A prospective study of the effects of lithium on thyroid function and on the prevalence of antithyroid antibodies. Psychol Med 1985; 15:55-61
7. Fyrö B, Petterson U, Sedvall G: Time course for the effect of lithium on thyroid function in men and women. Acta Psychiatr Scand 1973; 49:230-236
8. Smigan L, Wahlin A, Jacobsson L, von Knorring L: Lithium therapy and thyroid function tests: a prospective study. Neuropsychobiology 1984; 11:39-43
9. Sofuoglu S, Tutus A, Gönül AS, Bastünrk M, Köse K, Esel E: Thyroidal hormone profile in bipolar patients who were in short- and long-term lithium treatment. Eur Neuropsychopharmacol 1997; 7(suppl 2):S140-S141
10. Lombardi G, Panza N, Biondi B, DiLorenzo L, Lupoli G, Muscettola G, Carella C, Bellastella A: Effect of lithium treatment on hypothalamic-pituitary-thyroid axis: a longitudinal study. J Endocrinol Invest 1993; 16:259-263
11. Kusalic M, Engelsmann F: Predictors of lithium treatment responsiveness in bipolar patients: a two year prospective study. Neuropsychobiology 1998; 37:146-149
12. Gönül AS, Tutus A, Sofuoglu S, Esel E, Köse K, Aslan SS, Bastünrk M: Effects of lithium treatment on thyroid functions in remitted bipolar patients (abstract). Eur Neuropsychopharmacol 1996; 6(suppl):P12
13. Baumgartner A, von Stuckrad M, Müller-Oerlinghausen B, Gräf KJ, Kürten I: The hypothalamic-pituitary-thyroid axis in patients maintained on lithium prophylaxis for years: high triiodothyronine serum concentrations are correlated to prophylactic efficacy. J Affect Disord 1995; 34:211-218
14. Hatterer JA, Kocsis JH, Stokes PE: Thyroid function in patients maintained on lithium. Psychiatry Res 1988; 26:249-257
15. Kirkegaard C, Norlem N, Lauridsen UB, Bjorum N, Christiansen C: Prognostic value of thyrotropin releasing hormone stimulation test in endogenous depression. Acta Psychiatr Scand 1975; 52:170-177
16. Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM: Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 1997; 58:470-478
17. Denicoff KD, Smith-Jackson EE, Disney ER, Suddath RL, Leverich GS, Post RM: Preliminary evidence of the reliability and validity of the prospective life-chart methodology (LCM-p). J Psychiatry Res 1997; 5:593-603
18. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W: Modification of the Clinical Global Impression (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997; 73:159-171
19. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
20. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571
21. Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429-435
22. Spielberger CD, Gorsuch RL, Lushene RD: STAI Manual. Palo Alto, Calif, Consulting Psychologists Press, 1970
23. Endicott J, Spitzer RL, Fleiss JL, Cohen J: The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33:766-771
24. Kramlinger KG, Post RM: Addition of lithium carbonate to carbamazepine: hematological and thyroid effects. Am J Psychiatry 1990; 147:615-620
25. Bocchetta A, Cherchi A, Loviselli A, Mossa P, Velluzzi F, Derai R, DelZompo M: Six year follow up of thyroid function during lithium treatment. Acta Psychiatr Scand 1996; 94:45-43
26. Joffe RT, Levitt AJ: Major depression and subclinical (grade 2) hypothyroidism. Psychoneuroendocrinology 1992; 17:215-221
27. Prohaska ML, Stern RA, Nevels CT, Mason GA, Prange AJ: The relationship between thyroid status and neuropsychological performance in psychiatric outpatients maintained on lithium. Neuropsychiatry Neuropsychol Behav Neurol 1996; 9: 30-34
28. Marangell LB, Ketter TA, George MS, Pazzaglia PJ, Callahan AM, Parekh P, Andreason PJ, Horowitz B, Herscovitch P, Post RM: Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders. Am J Psychiatry 1997; 154:224-230
29. Kleiner J, Altshuler LL, Hendrik V, Hershman JM: Lithium-induced subclinical hypothyroidism: review of the literature and guidelines for treatment. J Clin Psychiatry 1999; 60:249-255
30. Bauer MS, Whybrow PC: Treatment of refractory rapid cycling with high dose levothyroxine: a preliminary study. Arch Gen Psychiatry 1990; 47:435-440
31. Stancer HC, Persad E: Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine: clinical observations. Arch Gen Psychiatry 1982; 39:311-312
32. Leibow D: L-Thyroxine for rapid-cycling bipolar illness (letter). Am J Psychiatry 1983; 140:1255
33. Bauer M, Hellweg R, Gräf KJ, Baumgartner A: Treatment of refractory depression with high dose thyroxine. Neuropsychopharmacology 1998; 18:444-455
34. 4 therapy in depression and hypothyroidism. Depression 1995; 2:278-280
35. Stratakis CA, Chrousos GP: Transient elevation of serum thyroid hormone levels following lithium discontinuation. Eur J Pediatr 1996; 155:939-941
36. Rao ML, Ruhrmann S, Retey B, Liappis N, Fuger J, Kraemer M, Kasper S, Moller HJ: Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome. Pharmacopsychiatry 1996; 29: 180-186
37. 3 augmentation. Psychiatry Res 1997; 69: 203-206
38. Roy-Byrne PP, Joffe RT, Uhde TW, Post RM: Carbamazepine and thyroid function in affectively ill patients: clinical and theoretical implications. Arch Gen Psychiatry 1984; 41:1150-1153
39. Shelton RC, Win S, Ekhatore N, Loosen PT: The effects of antidepressants on the thyroid axis in depression. Biol Psychiatry 1993; 33:120-126
40. Joffe R, Segal Z, Singer W: Change in thyroid hormone levels following response to cognitive therapy for major depression. Am J Psychiatry 1996; 153:411-413
41. Baumgartner A, Pinna G, Hiedra L, Gaio U, Hessenius C, Campos-Barros A, Eravci M, Prengel H, Thoma R, Meinhold H: Effects of lithium and carbamazepine on thyroid hormone metabolism in rat brain. Neuropsychopharmacology 1997; 16: 25-41
42. Baumgartner A, Gräf KJ, Kürten I, Meinhold H: The hypothalamic-pituitary-thyroid axis in psychiatric patients and healthy subjects: parts 1-4. Psychiatry Res 1988; 24:271-332
43. Herman R, Obarzanek E, Mikalauskas KM, Post RM, Jimerson DC: The effects of carbamazepine on resting metabolic rate and thyroid function in depressed patients. Biol Psychiatry 1991; 29:779-788
44. Ketter TA, Flockhart DA, Post RM, Denicoff KD, Pazzaglia PJ, Marangell LB, George MS, Callahan AM: The emerging role of cytochrome P450 3A in psychopharmacology. J Clin Psychopharmacol 1995; 15:387-398
45. Bentsen KD, Gram L, Veje A: Serum thyroid hormones and blood folic acid during monotherapy with carbamazepine or valproate. Acta Neurol Scand 1983; 67:235-241
46. Larkin JG, Macphee GJA, Beastall GH, Brodie MJ: Thyroid hormone concentrations in epileptic patients. Eur J Clin Pharmacol 1989; 36:213-216